MASSMUTUAL TRUST CO FSB/ADV - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 1 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSMUTUAL TRUST CO FSB/ADV ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$13,700
+10.1%
4,8240.0%0.00%
Q3 2023$12,446
-40.3%
4,8240.0%0.00%
-100.0%
Q2 2023$20,840
+182.3%
4,8240.0%0.00%
Q1 2023$7,381
+92162.5%
4,8240.0%0.00%
Q4 2022$8
-99.9%
4,8240.0%0.00%
Q3 2022$6,000
-40.0%
4,8240.0%0.00%
Q2 2022$10,000
-16.7%
4,8240.0%0.00%
Q1 2022$12,000
-33.3%
4,8240.0%0.00%
-100.0%
Q4 2021$18,000
-5.3%
4,8240.0%0.00%0.0%
Q3 2021$19,0004,8240.00%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,197,245$2,993,0001.24%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 265,000$663,0000.40%
COOPERMAN LEON G 812,508$2,031,2700.11%
Ikarian Capital, LLC 221,252$553,0000.07%
Shay Capital LLC 10,000$25,0000.00%
Sandy Cove Advisors, LLC 1,200$3,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,603$52,0000.00%
Newbridge Financial Services Group, Inc. 1,269$3,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$3,0000.00%
GROUP ONE TRADING, L.P. 20$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders